Advertisement

Related Videos

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Jun
25
Today In Oncology
Early Palliative Care Improves Quality of Life for Patients With Breast Cancer in India
Breast Cancer Palbociclib-Based Regimen Approved for HR-Positive, HER2-Positive Metastatic Disease
Advanced Breast Cancer Novel CDK4/6 Inhibitor Plus an Aromatase Inhibitor
FDA Approves Sacituzumab Govitecan-hziy as Monotherapy and in Combination With Pembrolizumab for First-Line Treatment of TNBC
Educational Gaps Found in Cardio-Oncology Training
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo